Causes of Hyperbilirubinemia
Hyperbilirubinemia is caused by an imbalance between bilirubin production and elimination, with three major categories of causes: prehepatic (excessive bilirubin production), intrahepatic (impaired bilirubin processing), and posthepatic (biliary obstruction). 1
Classification by Bilirubin Type
Unconjugated (Indirect) Hyperbilirubinemia
Prehepatic Causes
Hemolytic disorders:
Laboratory findings:
- Elevated reticulocyte count
- Decreased hemoglobin
- Abnormal red cell morphology
- Increased end-tidal carbon monoxide (ETCOc) 3
Intrahepatic Causes
Enzyme deficiencies:
- Gilbert syndrome (reduced glucuronosyltransferase activity) - affects 5% of the population 1
- Crigler-Najjar syndrome
Drug-induced:
- Certain antiviral medications can impair bilirubin conjugation 4
Conjugated (Direct) Hyperbilirubinemia
Intrahepatic Causes
Hepatocellular injury:
Cholestatic disorders:
- Primary biliary cholangitis
- Primary sclerosing cholangitis
- Medication-induced cholestasis 1
Posthepatic (Obstructive) Causes
Intrinsic biliary obstruction:
- Choledocholithiasis (gallstones in bile duct)
- Cholangitis
- Cholangiocarcinoma
- Gallbladder cancer 1
Extrinsic biliary compression:
Epidemiology of Causes
In the United States, the most common causes of jaundice fall into four categories:
- Hepatitis
- Alcoholic liver disease
- Blockage of common bile duct by gallstone or tumor
- Toxic reaction to drugs or medicinal herbs 1
In severe jaundice cases, European studies have found malignancy to be the most common cause, followed by sepsis/shock (22%), cirrhosis (21%), common bile duct stones (13%), drugs (0.5%), autoimmune hepatitis (0.2%), and viral hepatitis (0.2%) 1.
Special Populations
Neonates
- 60% of term and 80% of preterm infants develop jaundice in the first week of life 6
- Primarily due to immature liver conjugation systems
- Hemolytic disorders are a common cause of extreme neonatal hyperbilirubinemia 2
Post-procedural
- Severe hyperbilirubinemia after transjugular intrahepatic portosystemic shunts (TIPS) creation indicates poor prognosis
- Risk factors include non-alcoholic liver disease and prolonged prothrombin time 7
Diagnostic Approach
Fractionation of bilirubin to determine if elevation is predominantly conjugated or unconjugated 3
- Direct (conjugated) bilirubin >20-30% of total or >1.0 mg/dL when total bilirubin is ≤5 mg/dL indicates conjugated hyperbilirubinemia
Liver function tests:
- ALT, AST, alkaline phosphatase, GGT, albumin, PT/INR 3
Hemolysis evaluation:
- Complete blood count with differential
- Blood smear for red cell morphology
- Reticulocyte count 3
Imaging:
Common Pitfalls to Avoid
- Delayed evaluation of conjugated hyperbilirubinemia, which always represents pathology requiring prompt investigation 3
- Overdiagnosis and unnecessary testing for mild indirect hyperbilirubinemia 3
- Confusing direct bilirubin with conjugated bilirubin in laboratory reports 3
- Attributing mild indirect hyperbilirubinemia to significant liver disease when it may represent a benign variant like Gilbert's syndrome 3
- Failing to consider drug-induced causes, especially in patients on antiviral medications 4
Understanding the pattern of bilirubin elevation (conjugated vs. unconjugated) is the key first step in determining the underlying cause of hyperbilirubinemia and directing appropriate further evaluation.